High incidence of intermittent care in HIV-1-infected patients in Curaçao before and after starting cART

References

• Arici, C., Ripamonti, D., Maggiolo, F., Rizzi, M., Finazzi, M. G., Pezzotti, P., & Suter, F. (2002). Factors associated with the failure of HIV-positive persons to return for scheduled medical visits. HIV Clinical Trials, 3(1), 52–57. doi:10.1310/2XAK-VBT8-9NU9-6VAK
   PubMedGoogle Scholar
• Braitstein, P., Brinkhof, M. W., Dabis, F., Schechter, M., Boulle, A., Miotti, P., … Egger, M. (2006). Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: Comparison between low-income and high-income countries. [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Lancet, 367(9513), 817–824. doi:10.1016/S0140-6736(06)68337-2
   PubMed Web of Science ®Google Scholar
• Castilla, J., Del Romero, J., Hernando, V., Marincovich, B., Garcia, S., & Rodriguez, C. (2005). Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. [Comparative Study Research Support, Non-U.S. Gov't]. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 40(1), 96–101. doi:10.1097/01.qai.0000157389.78374.45
   PubMed Web of Science ®Google Scholar
• Chaisson, R. E., Keruly, J. C., & Moore, R. D. (2000). Association of initial CD4 cell count and viral load with response to highly active antiretroviral therapy. [Letter Research Support, U.S. Gov't, P.H.S.]. JAMA: The Journal of the American Medical Association, 284(24), 3128–3129. doi:10.1001/jama.284.24.3128
   PubMed Web of Science ®Google Scholar
• Cohen, C. J., Iwane, M. K., Palensky, J. B., Levin, D. L., Meagher, K. J., Frost, K. R., & Mayer, K. H. (1998). A national HIV community cohort: Design, baseline, and follow-up of the AmFAR Observational Database. American Foundation for AIDS Research Community-Based Clinical Trials Network. [Comparative Study Multicenter Study Research Support, Non-U.S. Gov't]. Journal of Clinical Epidemiology, 51(9), 779–793. doi:10.1016/S0895-4356(98)00043-2
   PubMed Web of Science ®Google Scholar
• Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., & Fleming, T. R. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. [Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. The New England Journal of Medicine, 365(6), 493–505. doi:10.1056/NEJMoa1105243
   PubMed Web of Science ®Google Scholar
• Daniel, N., Schneider, V., Pialoux, G., Krivine, A., Grabar, S., Nguyen, T. H., & Salmon, D. (2003). Emergence of HIV-1 mutated strains after interruption of highly active antiretroviral therapy in chronically infected patients. [Letter Research Support, Non-U.S. Gov't]. AIDS, 17(14), 2126–2129. doi:10.1097/01.aids.0000088183.01779.40
   PubMedGoogle Scholar
• Donnell, D., Baeten, J. M., Kiarie, J., Thomas, K. K., Stevens, W., Cohen, C. R., & Celum, C. (2010). Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Lancet, 375(9731), 2092–2098. doi:10.1016/S0140-6736(10)60705-2
   PubMed Web of Science ®Google Scholar
• El-Sadr, W. M., Lundgren, J. D., Neaton, J. D., Gordin, F., Abrams, D., Arduino, R. C., & Rappoport, C. (2006). CD4+count-guided interruption of antiretroviral treatment. [Comparative Study Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural]. The New England journal of medicine, 355(22), 2283–2296. doi:10.1056/NEJMoa062360
   PubMed Web of Science ®Google Scholar
• Graham, S. M., Holte, S. E., Peshu, N. M., Richardson, B. A., Panteleeff, D. D., Jaoko, W. G., & McClelland, R. S. (2007). Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. [Clinical Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. AIDS, 21(4), 501–507. doi:10.1097/QAD.0b013e32801424bd
   PubMed Web of Science ®Google Scholar
• Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009). Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet, 373(9657), 48–57. doi:10.1016/S0140-6736(08)61697-9
   PubMed Web of Science ®Google Scholar
• Gray, R. H., Wawer, M. J., Brookmeyer, R., Sewankambo, N. K., Serwadda, D., Wabwire-Mangen, F., & Quinn, T. C. (2001). Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. Lancet, 357(9263), 1149–1153. doi:10.1016/S0140-6736(00)04331-2
   PubMed Web of Science ®Google Scholar
• Gupta, P., Mellors, J., Kingsley, L., Riddler, S., Singh, M. K., Schreiber, S., & Rinaldo, C. R. (1997). High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. Journal of Virology, 71(8), 6271–6275. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9223532
   PubMed Web of Science ®Google Scholar
• Helleberg, M., Engsig, F. N., Kronborg, G., Larsen, C. S., Pedersen, G., Pedersen, C., & Obel, N. (2011). Retention in a public health care system with free access to treatment: A Danish nationwide HIV cohort study. AIDS. doi:10.1097/QAD.0b013e32834fa15e
   Web of Science ®Google Scholar
• Hermanides, H. S., Gras, L., Winkel, C. N., Gerstenbluth, I., van Sighem, A., de Wolf, F., & Duits, A. J. (2011). The efficacy of combination antiretroviral therapy in HIV type 1-infected patients treated in Curacao compared with Antillean, Surinam, and Dutch HIV type 1-infected patients treated in The Netherlands. [Comparative Study Research Support, Non-U.S. Gov't]. AIDS research and human retroviruses, 27(6), 605–612. doi:10.1089/aid.2010.0141
   PubMed Web of Science ®Google Scholar
• Hermanides, H. S., van Sighem, A., Winkel, C. N., Gerstenbluth, I., de Wolf, F., & Duits, A. J. (in press). Late start of cART as result of delayed entry into care in HIV-1 infected individuals in Curaçao. Unpublished manuscript.
   Google Scholar
• Karcher, H., Omondi, A., Odera, J., Kunz, A., & Harms, G. (2007). Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. [Research Support, Non-U.S. Gov't]. Tropical medicine & international health: TM & IH, 12(5), 687–694. doi:10.1111/j.1365-3156.2007.01830.x
   PubMed Web of Science ®Google Scholar
• Koenig, S. P., Rodriguez, L. A., Bartholomew, C., Edwards, A., Carmichael, T. E., Barrow, G., & Pape, J. W. (2012). Long-term antiretroviral treatment outcomes in seven countries in the Caribbean. Journal of acquired immune deficiency syndromes, 59(4), e60–e71. doi:10.1097/QAI.0b013e318245d3c1
   Google Scholar
• Lanoy, E., Mary-Krause, M., Tattevin, P., Dray-Spira, R., Duvivier, C., Fischer, P., & Costagliola, D. (2006). Predictors identified for losses to follow-up among HIV-seropositive patients. [Research Support, Non-U.S. Gov't]. Journal of clinical epidemiology, 59(8), 829–835. doi:10.1016/j.jclinepi.2005.11.024
   PubMed Web of Science ®Google Scholar
• Lebouche, B., Yazdanpanah, Y., Gerard, Y., Sissoko, D., Ajana, F., Alcaraz, I., & Mouton, Y. (2006). Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998. [Research Support, Non-U.S. Gov't]. HIV medicine, 7(3), 140–145. doi:10.1111/j.1468-1293.2006.00357.x
   PubMed Web of Science ®Google Scholar
• Ledergerber, B., von Overbeck, J., Egger, M., & Luthy, R. (1994). The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics. [Clinical Trial Controlled Clinical Trial Multicenter Study Research Support, Non-U.S. Gov't]. Sozial- und Praventivmedizin, 39(6), 387–394. doi:10.1007/BF01299670
   PubMedGoogle Scholar
• Marcelin, A. G., Tubiana, R., Lambert-Niclot, S., Lefebvre, G., Dominguez, S., Bonmarchand, M., & Poirot, C. (2008). Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma. [Research Support, Non-U.S. Gov't]. AIDS, 22(13), 1677–1679. doi:10.1097/QAD.0b013e32830abdc8
   PubMed Web of Science ®Google Scholar
• May, M. T., Sterne, J. A., Costagliola, D., Sabin, C. A., Phillips, A. N., Justice, A. C., & Egger, M. (2006). HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: A collaborative analysis. The Lancet, 368(9534), 451–458. doi:10.1016/S0140-6736(06)69152-6
   PubMed Web of Science ®Google Scholar
• Mocroft, A., Vella, S., Benfield, T. L., Chiesi, A., Miller, V., Gargalianos, P., & Lundgren, J. D. (1998). Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. The Lancet, 352(9142), 1725–1730. doi:10.1016/S0140-6736(98)03201-2
   PubMed Web of Science ®Google Scholar
• Montaner, J. S., Hogg, R., Wood, E., Kerr, T., Tyndall, M., Levy, A. R., & Harrigan, P. R. (2006). The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. [Review]. Lancet, 368(9534), 531–536. doi:10.1016/S0140-6736(06)69162-9
   PubMed Web of Science ®Google Scholar
• Mulissa, Z., Jerene, D., & Lindtjorn, B. (2010). Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia. [Research Support, Non-U.S. Gov't]. PLoS One, 5(10), e13268. doi:10.1371/journal.pone.0013268
   PubMed Web of Science ®Google Scholar
• Nacher, M., El Guedj, M., Vaz, T., Nasser, V., Randrianjohany, A., Alvarez, F., & Couppie, P. (2006). Risk factors for follow-up interruption of HIV patients in French Guiana. The American journal of tropical medicine & hygiene, 74(5), 915–917. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16687702
   PubMed Web of Science ®Google Scholar
• Ndiaye, B., Ould-Kaci, K., Salleron, J., Bataille, P., Bonnevie, F., Choisy, P., Yazdanpanah, Y. (2009a). Incidence rate and risk factors for loss to follow-up in HIV-infected patients from five French clinical centres in Northern France – January 1997 to December 2006. [Research Support, Non-U.S. Gov't]. Antiviral therapy, 14(4), 567–575. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19578242
   PubMed Web of Science ®Google Scholar
• Ndiaye, B., Ould-Kaci, K., Salleron, J., Bataille, P., Bonnevie, F., Cochonat, K., Yazdanpanah, Y. (2009b). Characteristics of and outcomes in HIV-infected patients who return to care after loss to follow-up. [Research Support, Non-U.S. Gov't]. AIDS, 23(13), 1786–1789. doi:10.1097/QAD.0b013e32832e3469
   PubMed Web of Science ®Google Scholar
• Ochieng-Ooko, V., Ochieng, D., Sidle, J. E., Holdsworth, M., Wools-Kaloustian, K., Siika, A. M., & Braitstein, P. (2010). Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Bulletin of the World Health Organization, 88(9), 681–688. doi:10.2471/BLT.09.064329
   PubMed Web of Science ®Google Scholar
• Phillips, A. N., Staszewski, S., Weber, R., Kirk, O., Francioli, P., Miller, V., & Ledergerber, B. (2001). HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. [Multicenter Study Research Support, Non-U.S. Gov't]. JAMA: The Journal of the American Medical Association, 286(20), 2560–2567. doi:10.1001/jama.286.20.2560
   PubMed Web of Science ®Google Scholar
• Sadiq, S. T., Taylor, S., Kaye, S., Bennett, J., Johnstone, R., Byrne, P., & Weller, I. (2002). The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis. [Research Support, Non-U.S. Gov't]. AIDS, 16(2), 219–225. doi:10.1097/00002030-200201250-00011
   PubMed Web of Science ®Google Scholar
• Schoeni-Affolter, F., Ledergerber, B., Rickenbach, M., Rudin, C., Gunthard, H. F., Telenti, A., & Francioli, P. (2010). Cohort profile: The Swiss HIV Cohort study. International journal of epidemiology, 39(5), 1179–1189. doi:10.1093/ije/dyp321
   PubMed Web of Science ®Google Scholar
• Severe, P., Leger, P., Charles, M., Noel, F., Bonhomme, G., Bois, G., & Fitzgerald, D. W. (2005). Antiretroviral therapy in a thousand patients with AIDS in Haiti. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. The New England journal of medicine, 353(22), 2325–2334. doi:10.1056/NEJMoa051908
   PubMed Web of Science ®Google Scholar
• Sterne, J. A., May, M., Costagliola, D., de Wolf, F., Phillips, A. N., Harris, R., & Cole, S. R. (2009). Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: A collaborative analysis of 18 HIV cohort studies. [Research Support, Non-U.S. Gov't Review]. Lancet, 373(9672), 1352–1363. doi:10.1016/S0140-6736(09)60612-7
   PubMed Web of Science ®Google Scholar
• Tuboi, S. H., Schechter, M., McGowan, C. C., Cesar, C., Krolewiecki, A., Cahn, P., & Shepherd, B. E. (2009). Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean. [Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Journal of acquired immune deficiency syndromes, 51(5), 615–623. doi:10.1097/QAI.0b013e3181a44f0a
   PubMedGoogle Scholar
• Ulett, K. B., Willig, J. H., Lin, H. Y., Routman, J. S., Abroms, S., Allison, J., & Mugavero, M. J. (2009). The therapeutic implications of timely linkage and early retention in HIV care. [Research Support, N.I.H., Extramural]. AIDS patient care and STDs, 23(1), 41–49. doi:10.1089/apc.2008.0132
   PubMed Web of Science ®Google Scholar